The feeling of transferring to the management position
Release time:
2020-07-22
transferred to the management position
transferred to the management position, I need to deal with more things in one day, but I only need to sort out and classify the work in one day: what are important things, what are urgent things, what are unimportant things, and what are not urgent things. Do urgent things first, then concentrate on important things. Subordinates can be entrusted to handle things that are not important or urgent. At the same time, improve the system and strengthen the implementation of the system, the routine management to the system, the exception management by their own to deal with, and the exception management to be summarized, the formulation of the corresponding system.
In the daily management process, I often encounter things that are not satisfactory in one way or another, but I personally feel that as long as I have the courage to change things that can be changed, have the mind to accept things that cannot be changed, and have the wisdom to distinguish The difference between the two can properly handle the problems encountered in the work. At the same time, in our work, we must make full use of the system, use the system to manage people and things, and achieve governance according to law, which can greatly improve management efficiency. Only by deeply implementing the system and allowing the system to establish prestige in the hearts of employees, employees will act in accordance with the law and their work effectiveness will be greatly improved.
Personally, I think the biggest test for a manager is not the manager's work effectiveness, but the employee's work effectiveness when the manager is away. In the absence of managers, employees can still maintain their work effectiveness, which means that the system has been deeply rooted in the hearts of the people and significant progress has been made in governance according to law. This is one of the important reasons why I adhere to the rule of law.
I am a person who loves to read history books, and I have read more history books, but I think crudely that since Emperor Wu of the Han Dynasty "ousted hundreds of schools and respected Confucianism alone", Confucian classics have gradually ruled the thoughts of scholars all over the world, and finally evolved into moral norms, developed into the basis of legal judgment, imprisoned people's thoughts, bound people's hands and feet, and stifled people's mind. If you also look at and judge things with personal feelings, right and wrong and moral values in management work, it will inevitably kill some new things, and it will inevitably be biased to judge a person, and it will inevitably lead to such or such problems. Therefore, I advocate that "observing the customs of the times and observing the country" should be based on establishing a system, taking the system as the criterion, supplemented by education and humanistic care, in order to seek governance. (Liu Bin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page